The U.S. Food and Drug Administration has approved a generic abortion drug without fanfare.
United States (National)
United States (National)


Not enough data
Sarah Silbiger's coverage focuses on government and politics, with a notable emphasis on healthcare and pharmaceutical topics. She extensively covers news related to Washington DC, the Senate, FDA announcements, and news conferences.
If you are reaching out to Sarah Silbiger, consider providing expert insights or analysis related to government policies, legal regulations in the healthcare sector as well as recent announcements by the FDA. Additionally, if you have any information about real estate developments specifically within Washington DC or news from Senate-related events that might be of interest for her reporting focus it would likely capture her attention.
This information evolves through artificial intelligence and human feedback. Improve this profile .